At a Glance
| Pentobarbital | Baclofen | |
|---|---|---|
| Class | Depressant | Depressant |
| Common Dose (oral) | 100–200 mg | 20–50 mg |
| Total Duration | 1.3–4 hrs | 2.5–4.8 hrs |
| Routes | oral | oral |
Dangerous Combination
Combining Pentobarbital and Baclofen is classified as dangerous. Combined CNS depression; risk of respiratory failure
Pentobarbital, a Depressant, and Baclofen, a Depressant, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Depressants, meaning they share a common pharmacological foundation. They share 14 documented effects in common, with 12 effects unique to Pentobarbital and 10 unique to Baclofen. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Pentobarbital | Baclofen | |
|---|---|---|
| Class | Depressant | Depressant |
| Common Dose (oral) | 100–200 mg | 20–50 mg |
| Total Duration | 1.3–4 hrs | 2.5–4.8 hrs |
| Routes | oral | oral |
| Effects |
| 26 documented |
| 24 documented |
| Interaction | Dangerous | |
| Level | Pentobarbital | Baclofen |
|---|---|---|
| Threshold | 25 mg | 5 mg |
| Light | 50–100 mg | 10–20 mg |
| Common | 100–200 mg | 20–50 mg |
| Strong | 200–300 mg | 50–100 mg |
| Heavy | — mg | 100 mg |
Pentobarbital
Baclofen
Combined CNS depression; risk of respiratory failure